[CIS PIDD] [cis-pidd] Chronic meningitis in ar-agammaglobulinemia

Harville, Terry O HarvilleTerryO at uams.edu
Mon May 11 15:47:19 EDT 2015


We had two children with Omaya reservoirs placed.  Removed 10 mL CSF and placed 10 mL 10% IVIg daily, back in the 1980s, virus was not classified at that time.  Peripheral IVIg dose was increased to 1 g/kg every two weeks.

If I remember correctly, we used the Omaya for about three months, with daily use (except maybe skipping a weekend day)…but left in place to see how symptoms went for another 6 months or so.  Then removed.  One patient developed hydrocephalus and required a shunt…this was not apparent while we were using the Omaya reservoir, perhaps due to some removal of CSF and that the IVIg was otherwise well-absorbed(?).

During the several years I had subsequently seen them…no obvious neurologic problems.

Again, these were young children (under 10 years of age).

Terry Harville MD PhD D(ABMLI) D(ABHI)
*Medical Director, Special Immunology Laboratory
*Medical Director, Histocompatibility Laboratory
*Medical Director, Immunogenetics and Transplantation Laboratory
*Specialist in Pediatric Allergy, Asthma, Immunology, Rheumatology,
Autoimmunity, Hematopoietic Stem cell Transplantation for
Immunodeficiencies, and Organ Transplantation Immunology
*Diplomate of the American Board of Medical Laboratory Immunology
– specializing in diagnostic evaluations of immunodeficiencies
*Diplomate of the American Board of Histocompatibility and Immunogenetics
– specializing in pre- and post-transplantation diagnostic evaluations,
disease associations, and platelet transfusion support

Departments of Pathology and Laboratory Services and Pediatrics
University of Arkansas for Medical Sciences
4301 West Markham
Mail Slot #502
Little Rock, AR  72205-7199

Email:...............................harvilleterryo at uams.edu

Office Phone 1..................................501.526.7511
Office Phone 2..................................501.686.7556
Office Fax......................................501.526.4621
Special Immunology Laboratory...................501.364.1804
Histocompatibility Laboratory...................501.686.7257
Histocompatibility Laboratory Fax...............501.686.7443
Immunogenetics and Transplantation Laboratory...501.686.7374

From: João Farela Neves [mailto:jpfn13 at gmail.com]
Sent: Saturday, May 9, 2015 06:03 AM
To: CIS-PIDD
Subject: Re: [cis-pidd] Chronic meningitis in ar-agammaglobulinemia

Thanks for your replies

Her trough levels are >17, already... (At least since February)

She has severe hydrocephaly and she is very symptomatic... We need to insert a csf draining device.

We planned ommaya to be placed next week but your experiences are not brilliant... Anyone else with different experiences?

Do you think it would be best to simply insert an external drainage while we try to identify the bug?

In the meanwhile We have identified tropheryma whipplei in the stools. PAS colorations and PCR in the duodenum are pending. Has anyone seen whipple's cns involvement in agammaglobulinemia?

Thanks for you precious help
Regards
João F Neves

João Farela Neves, MD


Infectious Diseases Unit



Primary Immunodeficiencies Unit



Clinical Immunology Working Party



Hospital Dona Estefania, Pediatric University Hospital



Rua Jacinta Marto, 1169-045



Lisbon, Portugal



Tel: +351 213126600<tel:%2B351%20213126600>



Fax:+351 213126963<tel:%2B351%20213126963>



E-mail 1: joao.farelaneves at chlc.min-saude.pt<mailto:joao.farelaneves at chlc.min-saude.pt>



E-mail 2: jpfn13 at gmail.com<mailto:jpfn13 at gmail.com>

No dia 09/05/2015, às 11:35, Richard Wasserman <drrichwasserman at gmail.com<mailto:drrichwasserman at gmail.com>> escreveu:
My older patient did well with IGIV when his IgG levels were >1500 mg/dL
Richard Wasserman

On Sat, May 9, 2015 at 4:25 AM, Pere Soler Palacin <psoler at vhebron.net<mailto:psoler at vhebron.net>> wrote:
Dear all, few years ago we had a similar XLA patient with enteroviral meningitis presenting as progressive dementia. We tried high dose IVIG (Ig levels always above 1000 mg/dl) without significant clinical response. Unluckily, when an Ommaya was placed CT showed massive bleed and the patient developed severe neurological sequeale. He's still alive but in a persistent vegetative state.
Pere.

Pere Soler Palacín, MD, PhD.
Pediatric Infectious Diseases and Immunodeficiencies Unit. Hospital Universitari Vall d'Hebron
Assistant Professor. Universitat Autònoma de Barcelona (UAB)
Pg. de la Vall d'Hebron, 119-129
08035 Barcelona. Spain.
Tel. 0034934893140  /  Fax 0034934893039

psoler at vhebron.net<mailto:psoler at vhebron.net>  /  34660psp at comb.cat<mailto:34660psp at comb.cat>
Web: www.upiip.com<http://www.upiip.com/>
ORCID ID: http://orcid.org/0000-0002-0346-5570
Scopus Author ID: http://www.scopus.com/authid/detail.url?authorId=55923378300
ResearchGate: http://www.researchgate.net/profile/Pere_Soler-Palacin
LinkedIn: http://es.linkedin.com/pub/pere-soler-palac%C3%ADn/73/918/b16


No imprimir aquest correu ajudarà a preservar el medi ambient.
Si vostè no és el destinatari del missatge, o l'ha rebut per error, si us plau notifiqui-ho al remitent i destrueixi el missatge amb tot el seu contingut. Està prohibida la distribució no autoritzada del contingut d'aquest missatge.

No imprimir este correo ayudará a preservar el medio ambiente.
Si usted no es el destinatario del mensaje, o lo ha recibido por error, notifíquelo por favor al remitente y destruya el mensaje con todo su contenido. Está prohibida la distribución no autorizada del contenido de este mensaje.

________________________________
De: "Richard Wasserman" <drrichwasserman at gmail.com<mailto:drrichwasserman at gmail.com>>
Per: "CIS-PIDD" <cis-pidd at lyris.dundee.net<mailto:cis-pidd at lyris.dundee.net>>
Enviats: Divendres, 8 de Maig 2015 16:24:59
Assumpte: Re: [cis-pidd] Chronic meningitis in ar-agammaglobulinemia

I have experience with two XLA patients with Echo 11 CNS infection.

The first presented in early childhood to Diane Wara in San Francisco. He was initially treated with IGIV but did not improve and an Ommaya resevoir was placed. He received IgG infusions several times a week and improved. He then developed non-communicating hydrocephalus and symptoms of spinal cord disease. Another resevoir was place in the lumbar region and he was treated through both ports and improved. The family then moved to Dallas and I began caring for him. Over time, we were able to decrease and finally discontinute intraventricular and intrathecal IgG. He did not have a recurrance of Echo 11 positivity. His peripheral IgG levels were always >1000mg/dL. In his teenage years he developed crippling paresis and contractures and died in his late 20's.

The second came to me at age 35 with chronic liver disease and wasting. He had been initially treated with IGIM and then FFP. When he grew Echo 11 from stool and LP was performed. There was no evidence of meningitis but the CSF grew Echo 11. Based on patient one, I had an Ommaya placed and began intraventricular IgG. A few hours after the first dose he developed neurologic changes and a CT showed a small bleed. Intraventricular IgG was stopped and he received high dose IGIV every two weeks. Shortly thereafter he received a liver transplant. Several years later he was doing well on home IGIV and decreased his dose. He developed a seizure and CSF was positive for Echo 11. IGIV was incresed and Echo 11 became undetectable. There were no further Echo 11 problems until his death 15 years later from chronic rejection.

Based on these experiences, I would push the IV dose hard before placing a resevoir for intraventricular/intrathecal IgG therapy. Good luck.
Richard Wasserman
Dallas

On Wed, May 6, 2015 at 5:45 AM, Joao Neves <jpfn13 at gmail.com<mailto:jpfn13 at gmail.com>> wrote:
Thank you for the reply.

Toscana will be searched in the biopsy and CSF. He is not on chronic SM-TMP nor NSAID.

Any other thoughts?

João FN
------------------------------------------------------------------------

4001310079135012


saude.pt<mailto:joao.farelaneves at chlc.min-saude.pt>

E-mail 2: jpfn13 at gmail.com<mailto:jpfn13 at gmail.com>

No dia 04/05/2015, às 20:24, Osman C Dokmeci <cdokmeci at gmail.com<mailto:cdokmeci at gmail.com>> escreveu:

Hi Dr. Neves,

Did you consider for Toscana Virus meningitis, or drug related causes (TMP-SMX) or NSAIDs?
Sometimes it escapes one's mind to look for these.

Osman C. Dokmeci, M.D.



On May 4, 2015, at 2:37 PM, João Farela Neves <jpfn13 at gmail.com<mailto:jpfn13 at gmail.com>> wrote:

Hello all

We've been asked to help a 16 YO female patient with agammaglobulinemia (ar, mu chain def). She is suffering from chronic meningitis and myelo-radiculitis.
"Standard" microbiologic procedures have failed to identify the causative organism in CSF/stools/blood (Including culture, PCR for virus and bacteria + 16S PCR)

Apparently she had Enteroviral meningitis in 2009 (fever+headaches+ CSF with pleocytosis and EV PCR +). Her doctors increased her IgG trough levels (>14) and her symptoms subsided. Since June 2014 her clinical condition has been deteriorating. In brief, her MRI reveals leptomeningitis, decompensated hydrocephalus because of decreased CSF absorption, and myelitis. She has severe headaches, difficulty walking (pyramidal signs and hypertonia) and has developed neurogenic bladder. She has persistent pleocytosis (lymph) and Enterovirus PCR is negative (5x). All other PCR and cultures are negative.

We have seen her last week and are planning brain biopsy to try to identify the micro-organism.

We are seeking your help because:
1-We need to send samples (brain biopsy + CSF) to a lab that is able to perform NGS for microbiologic identification. Can anyone help us with this?

2- We need to treat her hydrocephaly. We are favouring a Ommaya reservoir placement. Do you agree? Would you attempt intra-techal IgG administration through Ommaya’s reservoir? If you do, what would the posology be?

3- If we don’t succeed in the identification of the bug, would you attempt empirical treatment with alpha-IFN? With or without ribavirin?

4- Other thoughts?

Thanks in advance
Regards
João FN
------------------------------------------------------------------------

João Farela Neves, MD

Infectious Diseases Unit

Primary Immunodeficiencies Unit

Clinical Immunology Working Party

Hospital Dona Estefania, Pediatric University Hospital

Rua Jacinta Marto, 1169-045

Lisbon, Portugal

Tel: +351 213126600<tel:%2B351%20213126600>

Fax:+351 213126963<tel:%2B351%20213126963>

E-mail 1: joao.farelaneves at chlc.min-saude.pt<mailto:joao.farelaneves at chlc.min-saude.pt>

E-mail 2: jpfn13 at gmail.com<mailto:jpfn13 at gmail.com>

---

You are currently subscribed to cis-pidd as: cdokmeci at gmail.com<mailto:cdokmeci at gmail.com>.

To unsubscribe click here: http://cts.dundee.net/u?id=96396447.76597bd5aa8ed24781843b886dcacc34&n=T&l=cis-pidd&o=2806719

(It may be necessary to cut and paste the above URL if the line is broken)

or send a blank email to leave-2806719-96396447.76597bd5aa8ed24781843b886dcacc34 at lyris.dundee.net<mailto:leave-2806719-96396447.76597bd5aa8ed24781843b886dcacc34 at lyris.dundee.net>


---

You are currently subscribed to cis-pidd as: jpfn13 at gmail.com<mailto:jpfn13 at gmail.com>.

To unsubscribe click here: http://cts.dundee.net/u?id=96396694.fabc04a77cef150b44c3fafec21614f1&n=T&l=cis-pidd&o=2806820

(It may be necessary to cut and paste the above URL if the line is broken)

or send a blank email to leave-2806820-96396694.fabc04a77cef150b44c3fafec21614f1 at lyris.dundee.net<mailto:leave-2806820-96396694.fabc04a77cef150b44c3fafec21614f1 at lyris.dundee.net>


---

You are currently subscribed to cis-pidd as: drrichwasserman at gmail.com<mailto:drrichwasserman at gmail.com>.

To unsubscribe click here: http://cts.dundee.net/u?id=96396499.3449c9fd54f25f9fa0e022cb002b8c1e&n=T&l=cis-pidd&o=2811511

(It may be necessary to cut and paste the above URL if the line is broken)

or send a blank email to leave-2811511-96396499.3449c9fd54f25f9fa0e022cb002b8c1e at lyris.dundee.net<mailto:leave-2811511-96396499.3449c9fd54f25f9fa0e022cb002b8c1e at lyris.dundee.net>



--
Richard L. Wasserman, MD, PhD
Allergy Partners of North Texas
7777 Forest Lane, Suite B-332
Dallas, Texas 75230
Office (972) 566-7788<tel:%28972%29%20566-7788>
Fax (972) 566-8837<tel:%28972%29%20566-8837>
Cell (214) 697-7211<tel:%28214%29%20697-7211>

---

You are currently subscribed to cis-pidd as: psoler at vhebron.net<mailto:psoler at vhebron.net>.

To unsubscribe click here: http://cts.dundee.net/u?id=96396854.89ed69440aad1943e77ddad00dfd36f7&n=T&l=cis-pidd&o=2817071

(It may be necessary to cut and paste the above URL if the line is broken)

or send a blank email to leave-2817071-96396854.89ed69440aad1943e77ddad00dfd36f7 at lyris.dundee.net<mailto:leave-2817071-96396854.89ed69440aad1943e77ddad00dfd36f7 at lyris.dundee.net>


---

You are currently subscribed to cis-pidd as: drrichwasserman at gmail.com<mailto:drrichwasserman at gmail.com>.

To unsubscribe click here: http://cts.dundee.net/u?id=96396499.3449c9fd54f25f9fa0e022cb002b8c1e&n=T&l=cis-pidd&o=2819018

(It may be necessary to cut and paste the above URL if the line is broken)

or send a blank email to leave-2819018-96396499.3449c9fd54f25f9fa0e022cb002b8c1e at lyris.dundee.net<mailto:leave-2819018-96396499.3449c9fd54f25f9fa0e022cb002b8c1e at lyris.dundee.net>



--
Richard L. Wasserman, MD, PhD
Allergy Partners of North Texas
7777 Forest Lane, Suite B-332
Dallas, Texas 75230
Office (972) 566-7788
Fax (972) 566-8837
Cell (214) 697-7211

---

You are currently subscribed to cis-pidd as: jpfn13 at gmail.com<mailto:jpfn13 at gmail.com>.

To unsubscribe click here: http://cts.dundee.net/u?id=96396694.fabc04a77cef150b44c3fafec21614f1&n=T&l=cis-pidd&o=2819095

(It may be necessary to cut and paste the above URL if the line is broken)

or send a blank email to leave-2819095-96396694.fabc04a77cef150b44c3fafec21614f1 at lyris.dundee.net<mailto:leave-2819095-96396694.fabc04a77cef150b44c3fafec21614f1 at lyris.dundee.net>

---

You are currently subscribed to cis-pidd as: harvilleterryo at uams.edu<mailto:harvilleterryo at uams.edu>.

To unsubscribe click here: http://cts.dundee.net/u?id=96396614.2ee32e469ddab8c6a4acdac454c2cac0&n=T&l=cis-pidd&o=2819105

(It may be necessary to cut and paste the above URL if the line is broken)

or send a blank email to leave-2819105-96396614.2ee32e469ddab8c6a4acdac454c2cac0 at lyris.dundee.net<mailto:leave-2819105-96396614.2ee32e469ddab8c6a4acdac454c2cac0 at lyris.dundee.net>

----------------------------------------------------------------------
Confidentiality Notice: This e-mail message, including any attachments, is for the sole use of the intended recipient(s) and may contain confidential and privileged information. Any unauthorized review, use, disclosure or distribution is prohibited. If you are not the intended recipient, please contact the sender by reply e-mail and destroy all copies of the original message.

---
You are currently subscribed to cis-pidd as: pagid at list.clinimmsoc.org.
To unsubscribe click here: http://cts.dundee.net/u?id=96396833.5a9591ccd1e327fe6bc4d1543298c482&n=T&l=cis-pidd&o=2823601
or send a blank email to leave-2823601-96396833.5a9591ccd1e327fe6bc4d1543298c482 at lyris.dundee.net
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <https://pairlist7.pair.net/pipermail/pagid/attachments/20150511/a0129752/attachment-0001.html>


More information about the PAGID mailing list